Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMany people on Wegovy find eating becomes genuinely difficult, not just less appealing. Nausea, early fullness and a reduced appetite are among the most commonly reported effects in the STEP 1 clinical trial, where gastrointestinal symptoms affected a significant proportion of participants on semaglutide 2.4mg. That's the medicine working, in a real sense, but struggling to eat enough, especially enough protein, is a separate problem worth taking seriously. These are prescription-only medicines assessed for weight management, and any ongoing difficulty eating should be discussed with the prescriber overseeing your care.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP 1 trial, which followed 1,961 adults with obesity or overweight over 68 weeks, documented nausea in around 44% of participants on semaglutide 2.4mg, with vomiting and diarrhoea also common, particularly in the early weeks of treatment or following a dose step-up. Most of these effects were rated mild to moderate and resolved without stopping treatment. What the trial did not focus on, but what many people on Wegovy quickly discover, is that the appetite suppression can overshoot. You don't just want less food; sometimes you don't want any. If that resonates, it helps to understand why hunger changes so dramatically on Wegovy and what that means for day-to-day eating.
This is not a sign the medicine is too strong or that something has gone wrong. Semaglutide activates GLP-1 receptors that signal fullness to the brain and slow down how quickly the stomach empties. The result, for some people, is that a small amount of food feels enormous. The challenge then shifts from portion control to making sure each small meal carries enough nutritional weight to support your body through the weeks ahead. The right foods during Wegovy treatment matter more in this context, not less.
One misconception worth letting go gently: eating very little on Wegovy is not a faster route to results. Severe restriction without adequate protein accelerates the loss of lean muscle mass alongside fat, and muscle is metabolically active tissue you'll want to preserve. The NHS guidance on weight management injections is clear that lifestyle changes, including adequate nutrition, run alongside the medicine, not behind it. NHS England's guidance on weight-management injections sets out why wraparound dietary support is built into best practice.
The clinical picture is useful, but what actually helps when you sit down to eat and feel full after three bites? A few patterns come up repeatedly in practice.
Eating smaller amounts more frequently, rather than working towards three full meals, takes pressure off each sitting. If 200 calories of Greek yoghurt with some nuts is all that's manageable at lunchtime, that's a better outcome than forcing a full plate and feeling nauseated for the next two hours. Liquid protein, such as a plain protein shake with milk, sidesteps the texture and volume problem that makes solid food difficult for some people on Wegovy. Soft, easy-to-digest foods tend to be better tolerated on harder days.
Timing also helps. Many people find nausea is worse in the day or two immediately after the weekly injection, then improves through the rest of the week. Scheduling more demanding meals for later in the week, when the acute post-injection effect has settled, can make a real difference. Avoiding foods high in fat or sugar, which can sit heavily in a slower-moving stomach, reduces the risk of compounding the nausea. For a clearer list of what tends to help versus hinder, the foods that can make Wegovy side effects worse is worth reading alongside this.
Hydration is easy to neglect when eating feels hard. Dehydration from reduced food and fluid intake, particularly if vomiting has occurred, can cause kidney stress. Small, regular sips of water or diluted juice throughout the day matter.
There's a meaningful difference between finding meals less interesting and being genuinely unable to eat or keep food down. The first is an expected, manageable effect of semaglutide. The second warrants a conversation with a clinician.
Signs that deserve prompt attention include persistent vomiting that prevents you taking in any food or fluids, significant dizziness or weakness, and severe abdominal pain, particularly pain that radiates toward the back. The MHRA highlighted acute pancreatitis in January 2026 as an infrequent but serious risk with GLP-1 medicines: severe, persistent stomach pain with or without vomiting is a reason to seek urgent medical help, not to wait and see. The MHRA's Yellow Card scheme exists so patients can report suspected side effects directly, and it's a resource worth knowing about.
If eating difficulty is linked more to anxiety, a complicated relationship with food, or distress rather than physical nausea, that's also worth raising with your prescriber. Weight medicines sit alongside psychology, not above it.
People who find appetite suppression extreme early in treatment sometimes wonder whether staying at the current dose for longer, rather than stepping up, might help. That's a reasonable question, and one a prescriber can weigh up based on how you're doing. If you're navigating that kind of decision and want a clinical view, you're welcome to speak to our prescribers through a free consultation.
Protein is the priority. When total intake is low, protein should take the largest share of it. Muscle protein synthesis requires a consistent daily supply, roughly 1.2–1.6g per kilogram of body weight for people actively trying to preserve lean mass, though specific targets should be set with a dietitian or prescriber rather than approximated from general figures. Eggs, cottage cheese, fish, chicken, legumes and dairy all offer high protein per gram of food, which matters when volume tolerance is limited. Our guidance on what to eat when you are on Wegovy goes into more detail on building meals around these principles.
Iron, vitamin B12 and calcium can all fall short when eating is substantially reduced over weeks. If you're managing on very small amounts for an extended period, a blood test to check nutritional markers is sensible. Your GP can arrange this.
Strength training, even light resistance work, helps slow muscle loss during periods of caloric restriction. It doesn't need to be intense. Twenty minutes of bodyweight exercise three times a week is meaningfully better than nothing, and is compatible with how most people feel on Wegovy once the initial nausea phase passes.
For more detail on building meals that work with Wegovy's effects rather than against them, the foods that tend to work well on Wegovy offers practical, evidence-grounded guidance. And if appetite changes have left you wondering whether you're taking the right approach to treatment overall, the weight-loss treatment overview covers how different options compare.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.